- Home
- GOSS vs OZ Comparison
GOSS vs OZ Comparison
Compare GOSS & OZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- OZ
- Stock Information
- Founded
- GOSS 2015
- OZ 2020
- Country
- GOSS United States
- OZ United States
- Employees
- GOSS N/A
- OZ N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- OZ
- Sector
- GOSS Health Care
- OZ
- Exchange
- GOSS Nasdaq
- OZ Nasdaq
- Market Cap
- GOSS 212.9M
- OZ 255.0M
- IPO Year
- GOSS 2019
- OZ N/A
- Fundamental
- Price
- GOSS $0.74
- OZ $69.09
- Analyst Decision
- GOSS Strong Buy
- OZ
- Analyst Count
- GOSS 5
- OZ 0
- Target Price
- GOSS $9.20
- OZ N/A
- AVG Volume (30 Days)
- GOSS 881.6K
- OZ 2.3K
- Earning Date
- GOSS 11-07-2024
- OZ 01-01-0001
- Dividend Yield
- GOSS N/A
- OZ N/A
- EPS Growth
- GOSS N/A
- OZ N/A
- EPS
- GOSS N/A
- OZ N/A
- Revenue
- GOSS $105,322,000.00
- OZ $2,092,000.00
- Revenue This Year
- GOSS N/A
- OZ N/A
- Revenue Next Year
- GOSS N/A
- OZ N/A
- P/E Ratio
- GOSS N/A
- OZ N/A
- Revenue Growth
- GOSS N/A
- OZ N/A
- 52 Week Low
- GOSS $0.50
- OZ $42.75
- 52 Week High
- GOSS $1.60
- OZ $79.26
- Technical
- Relative Strength Index (RSI)
- GOSS 22.63
- OZ 58.49
- Support Level
- GOSS $0.78
- OZ $69.00
- Resistance Level
- GOSS $0.92
- OZ $69.78
- Average True Range (ATR)
- GOSS 0.05
- OZ 0.71
- MACD
- GOSS -0.01
- OZ 0.30
- Stochastic Oscillator
- GOSS 0.00
- OZ 80.74
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About OZ Belpointe PREP LLC Units
Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories.